In brief, neuronal activity arising from glioma-to-neuron interactions during tumor growth or seizure initiation seems to be a pivotal driver for BDNF release and identifies a potential biomarker of high-neural glioblastoma. The gene discussed is BDNF; the disease is central nervous system cancer.